sepiapterin reductase inhibitors (Amgen)

N/A

Report date: 2025/03/20 10:09:54
NME

Base Information

Drug Namesepiapterin reductase inhibitors (Amgen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSepiapterin reductase inhibitors
TargetsSepiapterin reductase
Therapy Area/IndicationsInflammationNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen Inc
Inactive CompaniesN/A
Active IndicationsInflammationNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A